ROBINSON JAMES GEORGE purchased 0.2% of their position (7K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $12.1K — a small addition. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 7/12/2019ACC: 0001651844-19-000023
Director
Since Oct 2018
+7K
Net shares
Net buyer
$12.1K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
7K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+5.83K
Price / share
$1.73
Trade value
$10.09K
% of position
0.2%
7/10/2019
3.50M→3.51M
Common Stock
Direct
Shares
+300.00
Price / share
$1.73
Trade value
$518.70
% of position
0.0%
7/10/2019
3.51M→3.51M
Common Stock
Direct
Shares
+600.00
Price / share
$1.72
Trade value
$1.03K
% of position
0.0%
7/10/2019
3.51M→3.51M
Common Stock
Direct
Shares
+166.00
Price / share
$1.73
Trade value
$286.76
% of position
0.0%
7/10/2019
3.51M→3.51M
Common Stock
Direct
Shares
+100.00
Price / share
$1.72
Trade value
$172.45
% of position
0.0%
7/10/2019
3.51M→3.51M
Total
Net shares
+7K
Net value
$12.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2019 | P · Purchase | +5.83K | $1.73 | $10.09K | 0.2% | 3.50M | 3.51M |
| Common Stock Direct | 7/10/2019 | P · Purchase | +300.00 | $1.73 | $518.70 | 0.0% | 3.51M | 3.51M |
| Common Stock Direct | 7/10/2019 | P · Purchase | +600.00 | $1.72 | $1.03K | 0.0% | 3.51M | 3.51M |
| Common Stock Direct | 7/10/2019 | P · Purchase | +166.00 | $1.73 | $286.76 | 0.0% | 3.51M | 3.51M |
| Common Stock Direct | 7/10/2019 | P · Purchase | +100.00 | $1.72 | $172.45 | 0.0% | 3.51M | 3.51M |
| Total | +7K | $12.10K | ||||||
Derivative Transactions0
No derivative transactions reported